Disclosures for " Influence of Novel Formulation in DaxibotulinumtoxinA on Efficacy for Treatment of Cervical Dystonia"
-
Dr. Lee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance.
-
Dr. Batista has received personal compensation for serving as an employee of Revance. Dr. Batista has stock in Revance.
-
Mr. Gallagher has received personal compensation for serving as an employee of Revance Therapeutics. Mr. Gallagher has stock in Revance Therapeutics.